Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (101-110 of 655) with videos related to

Pageof 66
Sort By:
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 26, 2012
Non-invasive prenatal diagnosis for Down syndrome: no paradigm shift, just better testing... and it is already here!E J Verweij, M A de Boer, D Oepkes
Investigational New Drugs|August 25, 2000
Development of multidrug-resistance convertors: sense or nonsense?L van Zuylen, K Nooter, A Sparreboom, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Combination chemotherapy of the taxanes and antimetabolites: its use and limitationsC H Smorenburg, A Sparreboom, M Bontenbal, et al.
Journal of Clinical Microbiology|April 3, 2001
Genetic Variation among Human Isolates of Uninucleated Cyst-Producing Entamoeba SpeciesJ J Verweij, A M Polderman, C G Clark
Oncology|June 1, 1996
Optimal control of acute cisplatin-induced emesisJ Verweij, R de Wit, P H de Mulder
Cancer Treatment and Research|January 1, 1989
Chemotherapy in advanced soft tissue sarcomasJ Verweij, C J van Groeningen, H M Pinedo
FASEB Bioadvances|November 11, 2021
In vivo imaging of EVs in zebrafish: New perspectives from "the waterside"Vincenzo Verdi, Anaïs Bécot, Guillaume van Niel, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumoursJ Verweij, A Planting, M van der Burg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Limited sampling model for area under the concentration time curve of total topotecanH Minami, J H Beijnen, J Verweij, et al.
Oncology Research|January 1, 1994
Clinical studies with EO9, a new indoloquinone bioreductive alkylating cytotoxic agent. EORTC Early Clinical Trials GroupJ Verweij, S Aamdal, J Schellens, et al.
Pageof 66

Showing results (101-110 of 655) with videos related to

Sort By:
Pageof 66
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 26, 2012
Non-invasive prenatal diagnosis for Down syndrome: no paradigm shift, just better testing... and it is already here!E J Verweij, M A de Boer, D Oepkes
Investigational New Drugs|August 25, 2000
Development of multidrug-resistance convertors: sense or nonsense?L van Zuylen, K Nooter, A Sparreboom, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Combination chemotherapy of the taxanes and antimetabolites: its use and limitationsC H Smorenburg, A Sparreboom, M Bontenbal, et al.
Journal of Clinical Microbiology|April 3, 2001
Genetic Variation among Human Isolates of Uninucleated Cyst-Producing Entamoeba SpeciesJ J Verweij, A M Polderman, C G Clark
Oncology|June 1, 1996
Optimal control of acute cisplatin-induced emesisJ Verweij, R de Wit, P H de Mulder
Cancer Treatment and Research|January 1, 1989
Chemotherapy in advanced soft tissue sarcomasJ Verweij, C J van Groeningen, H M Pinedo
FASEB Bioadvances|November 11, 2021
In vivo imaging of EVs in zebrafish: New perspectives from "the waterside"Vincenzo Verdi, Anaïs Bécot, Guillaume van Niel, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumoursJ Verweij, A Planting, M van der Burg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Limited sampling model for area under the concentration time curve of total topotecanH Minami, J H Beijnen, J Verweij, et al.
Oncology Research|January 1, 1994
Clinical studies with EO9, a new indoloquinone bioreductive alkylating cytotoxic agent. EORTC Early Clinical Trials GroupJ Verweij, S Aamdal, J Schellens, et al.
Pageof 66